Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
出版年份 2021 全文链接
标题
Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume -, Issue -, Pages -
出版商
EMBO
发表日期
2021-05-14
DOI
10.15252/emmm.202013270
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
- (2020) Claire Deligne et al. Cancer Immunology Research
- Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
- (2020) Rachael M. Zemek et al. Frontiers in Immunology
- Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation
- (2020) Zhi-Ling Li et al. Nature Communications
- Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma
- (2020) Caroline Spenlé et al. Cancer Immunology Research
- Keytruda and PD-L1: a Real-World Example of Co-development of a Drug with a Predictive Biomarker
- (2020) Kenneth Emancipator AAPS Journal
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Tenascin-C increases lung metastasis by impacting blood vessel invasions
- (2019) Zhen Sun et al. MATRIX BIOLOGY
- Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma
- (2018) Lucas A. Tomko et al. Scientific Reports
- Inhibition of dipeptidyl peptidase-4 accelerates epithelial-mesenchymal transition and breast cancer metastasis via the CXCL12/CXCR4/mTOR axis
- (2018) Fan Yang et al. CANCER RESEARCH
- Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma
- (2017) Zhaoting Yang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- The CXCL12/CXCR7 signaling axis, isoforms, circadian rhythms, and tumor cellular composition dictate gradients in tissue
- (2017) Phillip C. Spinosa et al. PLoS One
- Tenascin-C at a glance
- (2016) Kim S. Midwood et al. JOURNAL OF CELL SCIENCE
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
- (2016) S Lefort et al. ONCOGENE
- Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation
- (2015) E. Jachetti et al. CANCER RESEARCH
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Spatial organization of the tenascin-C microenvironment in experimental and human cancer
- (2015) Caroline Spenlé et al. Cell Adhesion & Migration
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- Identification and Characterization of Circulating Variants of CXCL12 from Human Plasma: Effects on Chemotaxis and Mobilization of Hematopoietic Stem and Progenitor Cells
- (2014) Rudolf Richter et al. STEM CELLS AND DEVELOPMENT
- CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems
- (2014) Alice Guyon Frontiers in Cellular Neuroscience
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Tenascin C Promiscuously Binds Growth Factors via Its Fifth Fibronectin Type III-Like Domain
- (2013) Laura De Laporte et al. PLoS One
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tenascin-C Downregulates Wnt Inhibitor Dickkopf-1, Promoting Tumorigenesis in a Neuroendocrine Tumor Model
- (2013) Falk Saupe et al. Cell Reports
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
- (2012) G. Erdag et al. CANCER RESEARCH
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2
- (2011) Chuang Chen et al. BIOMATERIALS
- Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
- (2011) Thordur Oskarsson et al. NATURE MEDICINE
- miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
- (2011) Espen Enerly et al. PLoS One
- The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis
- (2010) Chuang Chen et al. BIOMATERIALS
- Oxidative stress promotes myofibroblast differentiation and tumour spreading
- (2010) Aurore Toullec et al. EMBO Molecular Medicine
- Extracellular Matrix of Glioblastoma Inhibits Polarization and Transmigration of T Cells: The Role of Tenascin-C in Immune Suppression
- (2010) J.-Y. Huang et al. JOURNAL OF IMMUNOLOGY
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Collagen VI Is a Subepithelial Adhesive Target for Human Respiratory Tract Pathogens
- (2009) Marta Bober et al. Journal of Innate Immunity
- Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
- (2009) Kim Midwood et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now